The Lung Foundation of Malaysia (LFM) is a non-profit Foundation established in 2006 to gather funds to contribute towards the improvement of standard of care and treatment of patients with lung diseases.
Chronic lung diseases such as broncho-pulmonary dysplasia in children, chronic obstructive pulmonary disease in adults and asthma in both children and adults are among lung diseases that commonly inflict people and lead to prolonged suffering and disability. Care for these people can also be difficult and expensive especially if it involves the usage of life support devices.
In LFM, we offer support for patients afflicted with lung diseases so that they can lead a better quality of life with minimal suffering. We also seek to achieve paradigm shift by increasing the awareness and knowledge among the public on lung diseases and fund scientific researches related to improvement of treatment of the diseases.
Established by a group of medical professionals and corporate citizens fuelled with the determination to enable patients with lung diseases to get the best care and treatment and to live as healthily as possible, LFM aims to achieve the following:
i) To receive and administer funds for education, research and charitable purposes in relation to respiratory diseases for the public's welfare,
ii) To contribute towards scientific research, teaching, training and publication for the purpose of improving the knowledge, skills and care for patients in Malaysia,
iii) To organise and support schemes for the improvement of the standard of care of patients with lung diseases in this country, and
iv) To assist in the giving of relief to patients with chronic lung diseases.
Asthma is a common lung disease affecting about 300 million people worldwide. In Malaysia it is estimated about 1.5 million people of all ages suffer from asthma. As many as 50% children with asthma missed school and about a third of adults missed work because of asthma and many of these patients had to be hospitalized and experienced symptoms of uncontrolled disease. Suboptimal treatment and inadequate knowledge about the illness are factors contributed to poor control of asthma.
Chronic ventilatory failure is a condition whereby the respiratory muscle weakness or the chest wall deformity or both result in inefficient respiration. If left untreated, most patients will die of inadequate oxygen or excessive carbon dioxide or both, which is often a slow and agonizing death. The condition can be satisfactorily treated with oxygen supplement or breathing apparatus/ventilator which can be placed at patient’s home.
Chronic obstructive pulmonary disease disease affects almost exclusively adult smokers. Initial symptoms include cough with sputum production and difficulty in breathing initially on severe exertion but later on may be so debilitating that even walking a few steps can be a real struggle. In the terminal stage of the illness many patients would require continuous oxygen supplement to alleviate their breathlessness.
Bronchopulmonary dysplasia is a lung disease that occurs in premature neonates who needed oxygen therapy or mechanical ventilation during their early lives. The lung damage can be severe that long term oxygen may be required for many of these infants for a considerable period of time.
Good lung and heart health can change lives and build strong communities. One Breath
In any moment of decision, the best thing you can do is the right thing, the next best thing is the wrong thing, and the worst thing you can do is nothing. Theodore Roosevelt